Audits and Inspections

Size: px
Start display at page:

Download "Audits and Inspections"

Transcription

1 Audits and Inspections Dr. Dirk Feldmann 06. November 2017

2 First we take measurements, then we take measures. TECHNICAL

3 Content Audits and inspections Types of audits EHS Challenges and chances Preparation and escort Frequent observations Data integrity

4 Audits and inspections Pharmaceutical companies are often audited or inspected by: Regulatory authorities of home country Notified bodies for medical devices Regulatory authorities of receiving countries Customers Parent company (Global audits) In addition self inspections are an important GMP tool and are mandatory for manufacturers of medicinal drugs

5 Audits and inspections Besides specific GMP inspections you might be faced with additional inspections like EHS (environment, health and safety) Local surveillance authorities (labor protection, saftey) Local environmental protection agencies Employers mutual insurance associations EMAS = Eco-Management and Audit Scheme Customers (Work-Place-Conditions-Audit)

6 EHS Environment, health and safety (EHS) is a discipline and specialty that studies and implements practical aspects of environmental protection and safety at work. In simple terms it is what organizations must do to make sure that their activities do not cause harm to anyone. Regulatory requirements play an important role in EHS discipline and EHS managers must identify and understand relevant EHS regulations, the implications of which must be communicated to executive management so the company can implement suitable measures.

7 EHS From a health & safety standpoint, it involves creating organized efforts and procedures for identifying workplace hazards and reducing accidents and exposure to harmful situations and substances. It also includes training of personnel in accident prevention, accident response, emergency preparedness, and use of protective clothing and equipment.

8 Emergency and Alarm Plan TECHNICAL

9 Safety Instructions (Manufacturing) TECHNICAL

10 Safety Instructions (Laboratory) TECHNICAL

11 Boards with Operating Instructions TECHNICAL

12 Notice boards for work safety TECHNICAL

13 EHS From a health & safety standpoint, it involves creating organized efforts and procedures for identifying workplace hazards and reducing accidents and exposure to harmful situations and substances. It also includes training of personnel in accident prevention, accident response, emergency preparedness, and use of protective clothing and equipment. From an environmental standpoint, it involves creating a systematic approach to complying with environmental regulations, such as managing waste or air emissions all the way to helping site's reduce the company's carbon footprint.

14 Waste separation TECHNICAL

15 Key data TECHNICAL

16 Key data TECHNICAL

17 Audits and inspections Nevertheless audits and inspections offer a very good opportunity to: earn the trust of your local authorities regarding your compliance status and to convince and impress your customers.

18 Example: Bausch + Lomb Berlin plant Up to now Bausch + Lomb Berlin has conducted 5 GMP and 5 EHS audits in Notified body 1 International regulatory authorities 1 Customers 2 B+L global (annual audit) 1 Local regulatory authorities visit our plant every 3 years (expected in 2018)

19 Inspections by national authorities Africa = Europe = European Union = 55 countries 51 countries 28 countries

20 Mutual recognition agreements (MRAs) The European Union (EU) has signed mutual recognition agreements (MRAs) with third-country authorities concerning the conformity assessment of regulated products. Such agreements contain a sectoral annex on the mutual recognition of good manufacturing practice (GMP) inspections and batch certification of human and veterinary medicines. The EU has MRAs in place with: Australia, Canada; Israel, Japan, New Zealand, Switzerland, and the USA. (United States MRA has entered into force on November 1 st, 2017 but will be in transition phase until July 2019)

21 Audit announcement When you are informed of a planned visit to your facility you should start asking yourself many questions such as: Are we prepared? What do we need to do to get ready? Do we have the right attitude?

22 Audit announcement The right attitude is very important and determines the success or failure of the audit. Generally, as humans, we dislike inspections of any kind because we take it as criticism in what we have invested in. But remember: if you take criticism in a positive way, you will be able to comply with the set of regulations, improve your system, processes and more importantly, make your company grow.

23 Audit preparation Prepare your team and your staff by educating them about the process of an inspection. Train them how to interact with inspectors. You can prepare little business cards with helpful information and rules.

24

25 Audit preparation Prepare telephone lists with all numbers of employees and managers that will be needed during the audit. Each team member should have this list in his mobile phone directory.

26 Audit preparation Prepare check lists in each department with time frames and responsibilities. Managers have to update these lists and send them to their teams and must follow up of them. There should be sufficiant time to correct findings

27 : Manufacturing department packaging Due Date one week before audit o Control of all SOP print outs (version) o Control of all log books o Control of all balances (adjustment, calibration date) o Control of all watches (uniform time) o Empty and clean all working places o Control of trainings status o Control of cleaning protocols To do each morning during audit o Control of all personal and material locks o Empty all dustbins o Check for and remove all lose paper and post-its

28 Audit preparation Build an audit core team and define escorts that accompany each inspector. Escorts are responsible for recording the following points during a plant tour: all discussed topics open points that have to be clarified documents that the inspectors would like to see later All escorts should be equipped with cameras and mobile phones. If the inspector takes a picture during the plant tour the escort should take the same picture from the same spot.

29 Audit preparation During the office part of the audit your escorts should protocol the following: all documents and SOPs that were requested and inspected possible discusssion points and findings open points that have to be clarified later Your escort should use all time slots of the inspector to deliver missing documents or to clarify open points.

30 Audit preparation Implement a back office The back office is resonsible to organizing all documents or to prepare and deliver copies. They are the extended arm of the QA managment during the audit/inspection. Back office should contact needed team members or collegues that will be inspected next.

31 Audit language Audit language should always be english or your native language Organize a translater (reliable) for important inspections (e.g. asia) Be careful! - Inspector might understand your local language

32 Important organizational aspects One or two meeting rooms for the audit Projector, flip chart, power connection, WIFI Transport for the inspectors (if necessary) Coffee, tea, beverages, snacks and meals Starting presentation (plant leader) Hand out or inspection folder Visitor gowning (shoe size of inspectors) Empty locker for visitors Dinner? If yes, who will be with the inspectors

33 During the audit Same participants in opening and closing meeting Keep the round small Have business cards at hand Make sure everyone is availiable

34 During the audit If the inspector ask for documents, hurry up to make them availiable Long waiting time will sow the seeds of doubt in your filing system If you are not sure about an answer tell the inspector that you have to clarify it Wrong answers can bring you into big trouble If you can fix a finding during the audit (e.g. change in SOP) it might safe you an observation

35 After the audit Inform all employees at the end of each audit / inspection day about the outcome Always respond to the audit report within the given time frame Corrective Actions and/or Preventive Actions (CAPA) will be needed for all observations Due dates for CAPAs should be set carefully and with sufficiant time for implementation

36 Typical findings during inspections Quality assurance (QA): Missing GMP training Missing medical GMP checks Missing initial training records Missing job description Insufficiant handling of deviations and CAPA Missing quality agreements Insufficiant Change Control handling Weakness in PQR preparation

37 Example: Deviation handling QC lab detected a missing letter in the variable data on a folding box of batch 217. Exp. Date: Lot: 2 7 Manufacturing department detected a missing/dropped printing type as root cause. Correction: 100% control of batch backwards until first complete unit is found. After rework the batch was released and the deviation closed. What could be the observation? You have not detected the real root cause Due to this a CAPA is missing

38 Typical findings during inspections Quality control (QC): Missing or inadequate method validation Missing technology transfer (R+D QC lab) Inadequate sample handling Inadequate storage of reagents and standards OOS procedure / OOS handling Environmental montoring system Media Fills Log books and labeling

39 Example: Sample handling Samples of finished goods are sent to QC lab by manufacturing team and put into an incoming box. Possible questions: How do you make sure that you received all samples? Quantity? Who delivered the samples at what time point? How are the storage conditions? Are the samples secured against unauthorized access?

40 Example: Sample handling TECHNICAL

41 Example: Sample handling TECHNICAL

42 Example: Sample handling TECHNICAL

43 Example: Storage of standards Reference substances are stored under different conditions. Room temperatue, refrigerator, freezer Possible questions: How do you control the storage conditions? Are the substances secured against unauthorized access? How do you manage the administration?

44 Example: Storage of standards TECHNICAL

45 Example: Storage of standards TECHNICAL

46 Example: Storage of standards TECHNICAL

47 Example: Log books and labeling TECHNICAL

48 Typical findings during inspections Calibration / Validation: Missing process validation Missing or inadequate equipment qualification Weakness in recalibration program Missing cleaning validation Missing smoke studies

49 Example: Qualification status TECHNICAL

50 Example: Qualification status TECHNICAL

51 Typical findings during inspections Manufacturing: Inadequate facilities / housekeeping Documentation discrepancies (batch record) Monitoring system (temperature, pressure, humidity) Missing or inadequate in process control (IPC) Training of manufacturing personnel Sampling Storage of packaging materials

52 Storage of packaging materials WHO GMP-Guideline Particular attention should be paid to printed materials. They should be stored in secure conditions so as to exclude the possibility of unauthorized access. Roll feed labels should be used wherever possible. Cut labels and other loose printed materials should be stored and transported in separate closed containers so as to avoid mix ups.

53 Example: Storage of packaging materials Zip ties

54 Example: Access protection Output boxes

55 Typical findings during inspections Technical Department: Maintenance program Missing records for maintenance activities e.g. media system and manufacturing equipment HVAC system Water system Insufficiant pest control

56 Example: Pest control TECHNICAL

57 Typical findings during inspections Current No. 1 finding during FDA inspections Data integrity

58 Data integrity What is Data Integrity? The completeness, consistency, and accuracy of data throughout the data lifecycle. Complete, consistent and accurate data should be: A - attributable (data originator is uniquely identified) L - legible (readable and permanent) C - contemporaneous (activities recorded at the time of observation/data generation) O - original (or true copy) A accurate (information is correct, complete, valid) Controls over the data lifecycle shall exist and be established

59 ALCOA TECHNICAL

60 Examples A DataLoggerProgram is used for temperature monitoring. Only users with the approved access have access to download and print the graph. Records are saved onto the companies public drive (e.g. SharePoint). The drive does not have access restrictions. Non-approved access may result with the potential for unintentional data changes & deletion of results.

61 Examples Original worksheet had water damage. This was kept and included with the new transcribed sheet since this is considered to be the original record. Copy is compared to the original data set to verify that this is a true copy of the original source record.

62 Examples Scenario: Hybrid System After lab testing was completed the analyst discovered a typing mistake related to the lot number entry into the electronic program. Original Data= electronic data Error correction was made on paper record and must also be made in electronic record.

63 Thank You Very Much For Your Attention. PTB Q.5

STANDARD OPERATING PROCEDURE TEAM INSPECTIONS

STANDARD OPERATING PROCEDURE TEAM INSPECTIONS PHARMACEUTICAL INSPECTION CONVENTION PHARMACEUTICAL INSPECTION CO-OPERATION SCHEME PI 031-1 Annex 29 July 2009 STANDARD OPERATING PROCEDURE TEAM INSPECTIONS PIC/S July 2009 Reproduction prohibited for

More information

Lessons from Pharmaceutical Laboratory related FDA Warning Letters

Lessons from Pharmaceutical Laboratory related FDA Warning Letters Lessons from Pharmaceutical Laboratory related FDA Warning Letters The Agilent Critical Compliance Seminar 2016 Ludwig Huber Ludwig_huber@labcompliance.com Overview FDA Inspections and reports GMP compliance

More information

GMP The Other Side of Chemistry, Manufacturing & Controls (CMC)

GMP The Other Side of Chemistry, Manufacturing & Controls (CMC) Overview of USFDA Drug Regulatory Requirements Pharmaceutical Quality and Facility Inspections (GMP) Session II 19 February 2014 Casablanca, Morocco GMP The Other Side of Chemistry, Manufacturing & Controls

More information

CUSTOMER AND SUPPLIER ROLES AND RESPONSIBILITIES FOR 21 CFR 11 COMPLIANCE ASSESSMENT. 21 CFR Part 11 FAQ. (Frequently Asked Questions)

CUSTOMER AND SUPPLIER ROLES AND RESPONSIBILITIES FOR 21 CFR 11 COMPLIANCE ASSESSMENT. 21 CFR Part 11 FAQ. (Frequently Asked Questions) 21 CFR Part 11 FAQ (Frequently Asked Questions) Customer and Supplier Roles and Responsibilities for Assessment of METTLER TOLEDO STARe Software Version 16.00, including: - 21 CFR 11 Compliance software

More information

Documenta tion and Records

Documenta tion and Records Documenta tion and Records Page 1 of 30 Training Outcome of the Module: After completing this module, you will be able to: Recognize the importance of procedures Recognize the importance of record keeping

More information

HOW TO REDUCE COMPLIANCE RISK IN PACKAGING & LABELING

HOW TO REDUCE COMPLIANCE RISK IN PACKAGING & LABELING GUIDE HOW TO REDUCE COMPLIANCE RISK IN PACKAGING & LABELING Master Sample Contents Global Vision Systems 03 Where are manual inspection processes used? 04 Regulatory 04 Labeling 05 Manufacturing 06 The

More information

New Data Integrity Regulations and Practical Advice for Life Science Laboratories. we prove it.

New Data Integrity Regulations and Practical Advice for Life Science Laboratories. we prove it. 1 How to Meet New MHRA, FDA, EMA and WHO Data Integrity Guidelines white paper New Data Integrity Regulations and Practical Advice for Life Science Laboratories we prove it. 2 How to Avoid Poor Temperature

More information

A Comprehensive Approach to Find and Remediate Data Integrity Problems

A Comprehensive Approach to Find and Remediate Data Integrity Problems A Comprehensive Approach to Find and Remediate Data Integrity Problems June 14, 2017 Copyright 2017 QuintilesIMS. All rights reserved. What is data integrity? Whom does it apply to? Definitions matter

More information

Journal home page: RESEARCH ARTICLE

Journal home page:  RESEARCH ARTICLE Journal home page: http://www.journalijiar.com INTERNATIONAL JOURNAL OF INNOVATIVE AND APPLIED RESEARCH RESEARCH ARTICLE QUALITY AUDIT AND GMP INSPECTION OF PHARMACEUTICAL INDUSTRY WITH REFERENCE TO USFDA;

More information

Annex 4. Guidance on good manufacturing practices: inspection report. Background

Annex 4. Guidance on good manufacturing practices: inspection report. Background Annex 4 Guidance on good manufacturing practices: inspection report Background The need for revision of the Guidance on good manufacturing practices: inspection report (World Health Organization (WHO)

More information

Webinar Expert Module 3: GMP Inspections Dupont

Webinar Expert Module 3: GMP Inspections Dupont Webinar Expert Module 3: GMP Inspections Dupont 26 January & 9 February 2018 GOP-Innovations your Partner for Practical Training and e-learning Milenko Pavičić Pharmaceutical microbiologist, trainer, coach

More information

Could Poor Temperature Data Management be Putting Your GxP Facility at Risk for Data Integrity Violations? we prove it.

Could Poor Temperature Data Management be Putting Your GxP Facility at Risk for Data Integrity Violations? we prove it. 1 How to Meet New MHRA, FDA and WHO Data Integrity Guidelines WHITE PAPER Could Poor Temperature Data Management be Putting Your GxP Facility at Risk for Data Integrity Violations? we prove it. 2 How to

More information

Journal of Chemical and Pharmaceutical Research

Journal of Chemical and Pharmaceutical Research Available online www.jocpr.com Journal of Chemical and Pharmaceutical Research ISSN No: 0975-7384 CODEN(USA): JCPRC5 J. Chem. Pharm. Res., 2011, 3(6):88-98 Conduct of Inspections for Pharmaceutical Manufactures

More information

ISPE NORDIC COP CLEAN UTILITIES SEPTEMBER TUUSULA FINLAND. Timo Kuosmanen STERIS Finn-Aqua

ISPE NORDIC COP CLEAN UTILITIES SEPTEMBER TUUSULA FINLAND. Timo Kuosmanen STERIS Finn-Aqua ISPE NORDIC COP CLEAN UTILITIES SEPTEMBER 7 2016 TUUSULA FINLAND Timo Kuosmanen STERIS Finn-Aqua Timo_Kuosmanen@steris.com AUDIT TRAIL IN CRITICAL UTILITIES MONITORING CURRENT TRENDS CONTENTS BACKGROUND

More information

Impact of EU GMPs on Australian GMP. Trevor Schoerie PharmOut

Impact of EU GMPs on Australian GMP. Trevor Schoerie PharmOut Impact of EU GMPs on Australian GMP Trevor Schoerie PharmOut Part I Basic Requirements for Medicinal Products Current TGA Version, 7 years out of date TGA are actively and publically talking about PE009-0813

More information

DATA INTEGRITY ASSURANCE AS KEY FACTOR FOR SURVIVING CORPORATE AUDITS AND REGULATORY INSECTIONS

DATA INTEGRITY ASSURANCE AS KEY FACTOR FOR SURVIVING CORPORATE AUDITS AND REGULATORY INSECTIONS GLOBAL PROVIDER, LOCAL SOLUTIONS IN YOUR LANGUAGE DATA INTEGRITY ASSURANCE AS KEY FACTOR FOR SURVIVING CORPORATE AUDITS AND REGULATORY INSECTIONS Francesco Amorosi PhD Octorber 2017 DATA INTEGRITY & CSV:

More information

Impacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales. Innovacion en Packaging Primario

Impacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales. Innovacion en Packaging Primario Impacto de las Nuevas Tendencias Regulatorias en la Producción de Parenterales Innovacion en Packaging Primario 1 Contents Company Highlight What s Changing in Pharma Pharma Trends Harmonisation New Requirements

More information

QUALITY AGREEMENT. The following Agreement has been concluded between

QUALITY AGREEMENT. The following Agreement has been concluded between QUALITY AGREEMENT The following Agreement has been concluded between LLC LABORATORIES The contract laboratory and service provider 1625 Trinity Dr., Unit 11 Mississauga, Ontario Canada L5T 1W9 Hereinafter

More information

Internationally harmonised requirements for batch certification

Internationally harmonised requirements for batch certification 1 June 2011 EMA/INS/MRA/387218/2011 Rev 5 Compliance and Inspection Internationally harmonised requirements for batch certification in the context of Mutual Recognition Agreements, Agreements on Conformity

More information

COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS

COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS COMPLIANCE BY DESIGN FOR PHARMACEUTICAL QUALITY CONTROL LABORATORIES INSIGHT FROM FDA WARNING LETTERS Primer CONTENTS INTRODUCTION...3 QUALITY AND COMPLIANCE IN QUALITY CONTROL LABORATORIES...5 Compliance

More information

[ WHITE PAPER ] A Basic Overview: Meeting the PIC/S Requirements for a Computerized System INTRODUCTION GOOD MANUFACTURING PRACTICES

[ WHITE PAPER ] A Basic Overview: Meeting the PIC/S Requirements for a Computerized System INTRODUCTION GOOD MANUFACTURING PRACTICES A Basic Overview: Meeting the PIC/S Requirements for a Computerized System Lynn Archambault Waters Corporation, Milford, MA, USA INTRODUCTION The Pharmaceutical Inspection Convention and Pharmaceutical

More information

White paper: Code of GMP Chapter 4 Documentation - PIC/S versus EU

White paper: Code of GMP Chapter 4 Documentation - PIC/S versus EU White paper: Code of GMP Chapter 4 Documentation - PIC/S versus EU Numerous articles are available comparing the current and previous EU Code of GMP Chapter 4: Documentation, but no comparison exists between

More information

ISPE-FDA 3 rd Annual CGMP Conference 2 4 June 2014 Baltimore, MD. Detecting GMP Data Integrity Issues

ISPE-FDA 3 rd Annual CGMP Conference 2 4 June 2014 Baltimore, MD. Detecting GMP Data Integrity Issues Detecting GMP Data Integrity Issues Elaine Eborall Senior Director, GMP Compliance, Americas and Asia Pacific Compliance and External Collaboration ISPE-FDA cgmp Conference Baltimore, Maryland 2-4 June

More information

Prequalification Team WHO PUBLIC INSPECTION REPORT (WHOPIR) Active Pharmaceutical Ingredient (API) Manufacturer

Prequalification Team WHO PUBLIC INSPECTION REPORT (WHOPIR) Active Pharmaceutical Ingredient (API) Manufacturer Prequalification Team WHO PUBLIC INSPECTION REPORT (WHOPIR) Active Pharmaceutical Ingredient (API) Manufacturer PART 1: GENERAL INFORMATION Name of Manufacturer Calyx Chemicals & Pharmaceuticals Ltd Unit:

More information

UNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products

UNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products UNICEF s Quality Assurance System for Procurement of Finished Pharmaceutical Products UNICEF Industry Consultation with Manufacturers and Suppliers of Finished Pharmaceutical Products 29 th 30 th September

More information

18.H Questionnaire for preparing GMP-inspections

18.H Questionnaire for preparing GMP-inspections Questionnaire for preparing -inspections Questionnaire for preparing -inspections Here you will find answers to the following questions: What questions are typically asked during inspections based on current

More information

Technical updates medicines inspections: Finished Pharmaceutical Products (FPP)

Technical updates medicines inspections: Finished Pharmaceutical Products (FPP) Technical updates medicines inspections: Finished Pharmaceutical Products (FPP) Vimal Sachdeva, Technical Officer (Inspector) WHO Prequalification Team (PQT), WHO/HIS/EMP/RHT 20 Avenue Appia, CH - 1211,

More information

Supersedes Division Name Revision No. 0 Export Division Page No. 1 of 9

Supersedes Division Name Revision No. 0 Export Division Page No. 1 of 9 Page No. 1 of 9 Control Status 1.0 Purpose To lay down a procedure for conducting GMP inspection and report writing for issue of Written Confirmation for for medicinal products for human. 2.0 Scope This

More information

CRITICAL ASPECT ANALYTICAL TEST REVIEW

CRITICAL ASPECT ANALYTICAL TEST REVIEW CRITICAL ASPECT ANALYTICAL TEST REVIEW Jakarta 14 December 2017 Speaker: HERU PURNOMO, ST QC WORK FLOW Start Sample Received (In-Process & Finished Good) Testing Review Lab Result Yes No Non Conformance

More information

Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer

Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer Part 1: General information Name of Manufacturer Production Block Physical address Contact address Prequalification Team WHO PUBLIC INSPECTION REPORT Vaccine Manufacturer. Clean Utilities in the Basement.

More information

Quality System Regulation (QSR) Training

Quality System Regulation (QSR) Training Quality System Regulation (QSR) Training Or How to Ensure Development, Production and Sale of Safe, Effective, Consistent Product FDLI February 2003 Overview QSR History, Purpose and Scope Changes from

More information

How to Set Up a Quality Assurance System A Step by Step Guide to Quality Control Management System

How to Set Up a Quality Assurance System A Step by Step Guide to Quality Control Management System How to Set Up a Quality Assurance System A Step by Step Guide to Quality Control Management System By BizMove Management Training Institute Other free books by BizMove that may interest you: Free starting

More information

Price Electronics,LLC Quality Assurance Manual

Price Electronics,LLC Quality Assurance Manual Price Electronics,LLC QUALITY POLICY INTRODUCTION The purpose of this manual is to document the company s quality system, to instruct and guide employees whose actions affect product quality and to inform

More information

It s All About The RISK

It s All About The RISK Session Q 2: esource Document Verification A Case for CRF Mapping Glenda Guest It s All About The RISK What are some of the realized risks that auditors are observing? Multiple sources, how to ensure consistency

More information

U.S. EU Harmonization

U.S. EU Harmonization U.S. EU Harmonization by Pepe Rodriguez-Perez, PhD Business Excellence Consulting Inc BEC SPAIN SL www.calidadpr.com www.bec-global.com info@calidadpr.com info@bec-global.com Agenda Mutual Recognition

More information

Good manufacturing practices

Good manufacturing practices ORIGINAL PAPER 1AR-10 ISBT Science Series (2009) 4, 6 10 Journal compilation 2009 International Society of Blood Transfusion Good manufacturing practices Blackwell Publishing Ltd A. Ahmed Quality Manager,

More information

Prequalification of Medicines Programme

Prequalification of Medicines Programme Prequalification of Medicines Programme SOP 408.4 Annex A WHO PUBLIC INSPECTION REPORT Finished Product Manufacturer WHO PUBLIC INSPECTION REPORT (WHOPIR) Finished Product Manufacturer Part 1: General

More information

Top Annual 483 Observations: The Cycle of Quality June 2017 Presented by: Susan Schniepp

Top Annual 483 Observations: The Cycle of Quality June 2017 Presented by: Susan Schniepp Top Annual 483 Observations: The Cycle of Quality June 2017 Presented by: Susan Schniepp 2016 Regulatory Compliance Associates Inc. Top Observation for 5 years Year Drugs #1 citation Device #1 citation

More information

Inspection of API Manufacturers & Update on Registration Process

Inspection of API Manufacturers & Update on Registration Process Inspection of API Manufacturers & Update on Registration Process Catherine Neary, GMP Inspector GMP Conference 7 February 2017 Dublin Presentation Contents HPRA Inspection Programme for API Manufacturers

More information

Work plan for the GMP/GDP Inspectors Working Group for 2017

Work plan for the GMP/GDP Inspectors Working Group for 2017 13 January 2017 EMA/INS/GMP/584202/2016 Work plan for the GMP/GDP Inspectors Working Group for 2017 Chairperson: David Cockburn Adopted: December 2016 1. Meetings scheduled for 2017 Face-to-face meetings

More information

Preparing Your Aseptic Processing Facility for an FDA Inspection. Valerie Welter, Director Quality Bayer HealthCare March 10, 2014

Preparing Your Aseptic Processing Facility for an FDA Inspection. Valerie Welter, Director Quality Bayer HealthCare March 10, 2014 Preparing Your Aseptic Processing Facility for an FDA Inspection Valerie Welter, Director Quality Bayer HealthCare March 10, 2014 Agenda Regulatory Requirements Establishing your Approach Aseptic Controls

More information

Conducting Supplier Audits: Ensure Validation Compliance

Conducting Supplier Audits: Ensure Validation Compliance Conducting Supplier Audits: Ensure Validation Compliance Presented by: Gamal Amer, Ph. D. Principal Premier Compliance Services, Inc. All rights reserved. Do not copy without permission. 1 Outline Why

More information

Adopted by GCP Inspectors Working Group (GCP IWG) 29 November 2017

Adopted by GCP Inspectors Working Group (GCP IWG) 29 November 2017 13 June 2017 EMA/431270/2016 Annex VII to guidance for the conduct of good clinical practice inspections bioanalytical part, pharmacokinetic and statistical analyses of bioequivalence trials Adopted by

More information

GMP Compliance. George Acevedo, CQV Senior Engineer M+W Singapore Pte. Ltd

GMP Compliance. George Acevedo, CQV Senior Engineer M+W Singapore Pte. Ltd GMP Compliance George Acevedo, CQV Senior Engineer M+W Singapore Pte. Ltd June 2017 Overview GMP Definition and Regulation Our Philosophy and Strategy for Compliance Project Lifecycle Deliverables Master

More information

CERTIFIED MAIL RETURN RECEIPT REQUESTED

CERTIFIED MAIL RETURN RECEIPT REQUESTED Department of Health and Human Services Public Health Service Food and Drug Administration Warning Letter WL: 320-14-11 CERTIFIED MAIL RETURN RECEIPT REQUESTED June 16, 2014 Jeremy B. Desai, PhD President

More information

Ensure Data Integrity Compliance Enterprise-Wide

Ensure Data Integrity Compliance Enterprise-Wide Ensure Data Integrity Compliance Enterprise-Wide PharmaQual 360 º Conference February 24, 2017 Chris Wubbolt QACV Consulting, LLC www.qacvconsulting.com 1 Objectives What is data integrity and the definition

More information

Data Integrity for Your Laboratory Computerized Systems

Data Integrity for Your Laboratory Computerized Systems Data Integrity for Your Laboratory Computerized Systems Lynn Archambault, Informatics and Regulatory Compliance Product Marketing Manager, Waters Corporation INTRODUCTION Electronic data and computerized

More information

FDA Quality Metrics, Data Integrity and Application of Statistics Throughout Process Validation in a Global Economy

FDA Quality Metrics, Data Integrity and Application of Statistics Throughout Process Validation in a Global Economy CBI Statistics in Validation FDA Quality Metrics, Data Integrity and Application of Statistics Throughout Process Validation in a Global Economy Jerry Lanese Ph.D. The Lanese Group, Inc. 2017 The Lanese

More information

mechanism. GMP certificates Belén Escribano, PhD Head of the Pharmaceutical Inspection and Enforcement Department of AEMPS

mechanism. GMP certificates Belén Escribano, PhD Head of the Pharmaceutical Inspection and Enforcement Department of AEMPS Mutual recognition: basic aspects and mechanism. GMP certificates Belén Escribano, PhD Head of the Pharmaceutical Inspection and Enforcement Department of AEMPS The EU network of medicines agencies 31

More information

Overcome the Top Challenges of Handling OOS Results by Knowing FDA Observations

Overcome the Top Challenges of Handling OOS Results by Knowing FDA Observations Overcome the Top Challenges of Handling OOS Results by Knowing FDA Observations Jerry Lanese Ph.D. The Lanese Group, Inc. 2015 The Lanese Group, Inc. 1 Who decided you should come to this conference? On

More information

REGULATION REGARDING EQUIPMENT PROCUREMENT PROCESS AND APPROVAL OF MANUFACTURERS FOR NUCLEAR FACILITIES

REGULATION REGARDING EQUIPMENT PROCUREMENT PROCESS AND APPROVAL OF MANUFACTURERS FOR NUCLEAR FACILITIES REGULATION REGARDING EQUIPMENT PROCUREMENT PROCESS AND APPROVAL OF MANUFACTURERS FOR NUCLEAR FACILITIES SECTION ONE Purpose, Scope, Basis, Definitions and General Considerations Purpose and scope ARTICLE

More information

Implementation & Documentation Requirements for ISO 22716:2007 Certification

Implementation & Documentation Requirements for ISO 22716:2007 Certification Implementation & Documentation Requirements for ISO 22716:2007 Certification ISO 22716 is an international standard that gives guidance for the production, control, storage and shipment of cosmetic products.

More information

Introduction to Medicines Inspections Technical Updates:

Introduction to Medicines Inspections Technical Updates: Introduction to Medicines Inspections Technical Updates: GMP inspections of Active Pharmaceutical Ingrédients and Finished Pharmaceutical Products (including Reproductive Health Products) Vimal Sachdeva,

More information

Work plan for the GMP/GDP Inspectors Working Group for 2018

Work plan for the GMP/GDP Inspectors Working Group for 2018 30 November 2017 EMA/INS/GMP/504401/2017 Inspections, Human Medicines Pharmacovigilance & Committees Division Work plan for the GMP/GDP Inspectors Working Group for 2018 Chairperson: Brendan Cuddy Adopted:

More information

Incremental GMPs. Presented by: Karen S. Ginsbury For: IFF October 31, Nov 02, PCI Pharmaceutical Consulting Israel Ltd.

Incremental GMPs. Presented by: Karen S. Ginsbury For: IFF October 31, Nov 02, PCI Pharmaceutical Consulting Israel Ltd. Incremental GMPs Presented by: Karen S. Ginsbury For: IFF October 31, Nov 02, 2017 1/55 Sound Science Good Development Practice Traceability R&D Tox I II III IV What You Need Here Can t be generated here

More information

Contents. Contents (13) 1 Production (23)

Contents. Contents (13) 1 Production (23) 1 Production (23) 1.A Sanitation (27) 1.A.1 Organisational prerequisites (27) 1.A.2 Sources of contamination (28) 1.A.3 Responsibilities and implementation (29) 1.B Personnel hygiene (31) 1.B.1 Clothing

More information

International Procurement and supply Schemes Part II

International Procurement and supply Schemes Part II International Procurement and supply Schemes Part II by Dr. Nora Dellepiane Workshop: Global Registra8on and Vaccine Shortage Taipei, Taiwan 6 to 10 March 2017 Outline of the presentation Vaccine Supply

More information

GxP Auditing, Remediation, and Staff Augmentation

GxP Auditing, Remediation, and Staff Augmentation GxP Auditing, Remediation, and Staff Augmentation TABLE OF CONTENTS 3 Introduction 4 GxP Auditing 4 GMP Auditing 5 GCP Auditing 6 GLP Auditing 7 Pharmacovigilance Auditing 7 Vendor/Supplier Auditing 8

More information

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union EUROPEAN COMMISSION HEALTH AND CONSUMERS DIRECTORATE-GENERAL Public Health and Risk Assessment Pharmaceuticals Brussels, SANCO/C8/AM/sl/ares(2010)1064599 EudraLex The Rules Governing Medicinal Products

More information

Library Guide: Active Pharmaceutical

Library Guide: Active Pharmaceutical Library Guide: Active Pharmaceutical Ingredients (API) Table of Contents Overview...3 Sample Curriculum...5 Course Descriptions: A Step-by-Step Approach to Process Validation (PHDV79)...7 A Tour of the

More information

GUIDANCE ON THE GMP CLEARANCE OF OVERSEAS MEDICINE MANUFACTURERS

GUIDANCE ON THE GMP CLEARANCE OF OVERSEAS MEDICINE MANUFACTURERS GUIDANCE ON THE GMP CLEARANCE OF OVERSEAS MEDICINE MANUFACTURERS 16 th Edition March 2008 www.tga.gov.au/manuf/gmpsom.htm Page 1 of 18 Table of Contents Introduction... 3 International Arrangements...

More information

Inspections Dealing with Difficult Situations Medmarc Insurance Webinar

Inspections Dealing with Difficult Situations Medmarc Insurance Webinar Inspections Dealing with Difficult Situations Medmarc Insurance Webinar Steven Niedelman Lead Quality System & Compliance Consultant King & Spalding LLP 1700 Pennsylvania Ave., NW Washington, DC 20006

More information

Regulatory Overview Annex 11 and Part 11. Sion Wyn Conformity +[44] (0)

Regulatory Overview Annex 11 and Part 11. Sion Wyn Conformity +[44] (0) Regulatory Overview Annex 11 and Part 11 Sion Wyn Conformity +[44] (0) 1492 642622 sion.wyn@conform-it.com 1 Two Key Regulations Annex 11 21 CFR Part 11 Apply to the regulated company, but often have a

More information

Inspection Trends. American Society for Quality Richmond, VA Section March 8, 2016

Inspection Trends. American Society for Quality Richmond, VA Section March 8, 2016 Inspection Trends American Society for Quality Richmond, VA Section March 8, 2016 Brooke K. Higgins, Senior Policy Advisor CDER / Office of Compliance Office of Manufacturing Quality Division of Drug Quality

More information

PROPOSED NEW SECTIONS FOR WHO GOOD MANUFACTURING PRACTICES (GMP): MAIN PRINCIPLES FOR PHARMACEUTICAL PRODUCTS DRAFT FOR COMMENT

PROPOSED NEW SECTIONS FOR WHO GOOD MANUFACTURING PRACTICES (GMP): MAIN PRINCIPLES FOR PHARMACEUTICAL PRODUCTS DRAFT FOR COMMENT August 2010 RESTRICTED PROPOSED NEW SECTIONS FOR WHO GOOD MANUFACTURING PRACTICES (GMP): MAIN PRINCIPLES FOR PHARMACEUTICAL PRODUCTS DRAFT FOR COMMENT Please address any comments on this draft guideline

More information

Regulation of a common system of joint inspections of sites and sampling goods (products), subjected to veterinary control (supervision)

Regulation of a common system of joint inspections of sites and sampling goods (products), subjected to veterinary control (supervision) Regulation of a common system of joint inspections of sites and sampling goods (products), subjected to veterinary control (supervision) APPROVED by the Decision of the Customs Union Commission on June

More information

Standard operating procedures revisited: a 2014 perspective

Standard operating procedures revisited: a 2014 perspective Pharmaceutical Pharm. Bioprocess. (2014) 2(1), 41 47 Standard operating procedures revisited: a 2014 perspective Approximately 50 years after the good manufacturing practice (GMP) regulations were first

More information

Page 1 of 5 Home Inspections, Compliance, Enforcement, and Criminal Investigations Compliance Actions and Activities Warning Letters 2014 Inspections, Compliance, Enforcement, and Criminal Investigations

More information

Vendor Qualification Survey

Vendor Qualification Survey 1200 West 96 th St Minneapolis, MN 55431 Ph: 952-888-7900 Fax: 952-888-2719 Vendor Qualification Survey Vendor Information Company Name: Date: Address: City: Phone Number: email address: Product or Service

More information

Quality Assurance in Pharmaceutical and Biotech Industries as Per Regulatory Guidelines

Quality Assurance in Pharmaceutical and Biotech Industries as Per Regulatory Guidelines Human Journals Review Article January 2017 Vol.:8, Issue:2 All rights are reserved by Chagi Venkatesh et al. Quality Assurance in Pharmaceutical Biotech Industries as Per Regulatory Guidelines Keywords:

More information

Change Control Overview

Change Control Overview Change Control Overview Kelly Thomas Atlantic Technical and Validation Services Copyright 2014 by Atlantic Technical and Validation Services, LLC. 1 Session Outline Discuss Regulations Governing Change

More information

FDA Drug Compliance. Pepe Rodriguez-Perez, PhD Business Excellence Consulting Inc / BEC Spain SL.

FDA Drug Compliance. Pepe Rodriguez-Perez, PhD Business Excellence Consulting Inc / BEC Spain SL. FDA Drug Compliance Presented by Pepe Rodriguez-Perez, PhD Business Excellence Consulting Inc / BEC Spain SL www.calidadpr.com email pepe@calidadpr.com Agenda 1. FDA s Strategic Priorities 2014-18 2. CDER

More information

SAFETY CULTURE IN ITALY: THE LEGISLATION, INSPECTIONS, THE PERSPECTIVE OF AN INSPECTOR

SAFETY CULTURE IN ITALY: THE LEGISLATION, INSPECTIONS, THE PERSPECTIVE OF AN INSPECTOR SAFETY CULTURE IN ITALY: THE LEGISLATION, INSPECTIONS, THE PERSPECTIVE OF AN INSPECTOR Fabrizio Vazzana ISPRA-Italian National Institute for Environmental Protection and Research AIM: Analyze the dissemination

More information

Overview of Regulatory Requirements for API and Formulations

Overview of Regulatory Requirements for API and Formulations Overview of Regulatory Requirements for API and Formulations Sangeeta Sardesai 4-Dec-2010 Definition - Regulatory Requirement The restrictions, licenses, and laws applicable to a product or business, imposed

More information

DECEMBER 2008 GUIDANCE NOTES ON PRODUCT QUALITY REVIEW

DECEMBER 2008 GUIDANCE NOTES ON PRODUCT QUALITY REVIEW DECEMBER 2008 GUIDANCE NOTES ON PRODUCT QUALITY REVIEW 1.0 INTRODUCTION: The purpose of this guidance is to communicate the expectation with regard to the conduct of Product Quality Review. Product Quality

More information

White paper Audits in automated production

White paper Audits in automated production White paper Audits in automated production data management for automation Introduction: Audits in automated production In the field of production management, audits have become an important tool for analysing

More information

Inspection. Implementation of ICH Q8, Q9, Q10

Inspection. Implementation of ICH Q8, Q9, Q10 Implementation of ICH Q8, Q9, Q10 International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use Outline Aim of - as a key part of the regulatory

More information

Good Documentation Practices. Documentation Requirements For Regulated Environments

Good Documentation Practices. Documentation Requirements For Regulated Environments Good Documentation Practices Documentation Requirements For Regulated Environments Agenda Example Deficiency 2014 Result Of Poor Record Creation Data Integrity EU GMP Chapter 4 Requirements Non GMP Compliant

More information

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union

EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL. EudraLex The Rules Governing Medicinal Products in the European Union EUROPEAN COMMISSION ENTERPRISE AND INDUSTRY DIRECTORATE-GENERAL Consumer goods Pharmaceuticals Brussels, 25 October 2005 EudraLex The Rules Governing Medicinal Products in the European Union Volume 4 EU

More information

Quality Management System

Quality Management System Quality Management System ZYQ Testing Laboratory 11111 Testing Avenue Testing Town, Alaska 22222 (555) 555-5555 Date Prepared: January 19, 2009 1 Please note that this Quality Management System (QM) was

More information

ALCOA AND DATA INTEGRITY: PASTAND FUTURE

ALCOA AND DATA INTEGRITY: PASTAND FUTURE ALCOA AND DATA INTEGRITY: PASTAND FUTURE Marina Figini, PCA S.p.A./Aschimfarma Data Integrity: reliability, quality and competitiveness factors of API manufacturers Pavia, 10 Novembre 2017 Good data management

More information

Registered Starting Material Auditing Guide

Registered Starting Material Auditing Guide Registered Starting Material Auditing Guide Annex 1 Aide Mémoire Company : Auditor(s) : Location, Country : Date of Audit: APIC Guide for Auditing Registered Starting Material Manufacturers Remark: Non-compliance

More information

American Association for Laboratory Accreditation

American Association for Laboratory Accreditation ISO 15189 Page 1 of 17 Accredited clinical laboratories are required to meet the following additional requirements as contained in P905 - A2LA Metrological Traceability Policy for ISO 15189 Laboratory

More information

Certified Welding Fabricator (CWF) Program Information

Certified Welding Fabricator (CWF) Program Information Certified Welding Fabricator (CWF) Program Information (The enclosed documents provide information about the AWS Certified Welding Fabricator Program.) General Program Information Program Requirements

More information

Latino America Consultores Innovation & Technology to make your Business Compliant

Latino America Consultores Innovation & Technology to make your Business Compliant Latino America Consultores Innovation & Technology to make your Business Compliant Annex 15 & EMA Process Validation Guide Line 1 Changes in Requirements The Pharmaceutical Industry has adapted its business

More information

Good Manufacturing Practices Purpose and Principles of GMP. Tony Gould

Good Manufacturing Practices Purpose and Principles of GMP. Tony Gould Good Manufacturing Practices Purpose and Principles of GMP Tony Gould Why GMP? Provides a high level assurance that medicines are manufactured in a way that ensures their safety, efficacy and quality Medicines

More information

Serving Patients is a Privilege

Serving Patients is a Privilege Serving Patients is a Privilege This Privilege Comes with Significant Responsibilities Understanding Requirements for Data Integrity How to Develop a Data Integrity Program Including Data Integrity with

More information

MEDICAL DEVICES. Medical Device Manufacturing License. Facility Layout Design as per various regulatory requirements. Clean room and HVAC consultation

MEDICAL DEVICES. Medical Device Manufacturing License. Facility Layout Design as per various regulatory requirements. Clean room and HVAC consultation MEDICAL DEVICES With more than 100,000 individual medical devices on the market, patients have access to an astonishing array of products that can improve health and extend life. But the safety concerns

More information

LEGAL REQUIREMENTS and DATA INTEGRITY...

LEGAL REQUIREMENTS and DATA INTEGRITY... LEGAL REQUIREMENTS and DATA INTEGRITY... 1 1 DI Guidances MHRA GMP DI Definitions & Guidance for Industry, March 2015 Guidance on Good Data & Record Management, March, 2016 Data Integrity and Compliance

More information

Quality Manual. Index

Quality Manual. Index This quality policy manual is for the use of, its Clients, Vendors, and the appropriate Regulatory Agencies. Unauthorized duplication or transfer to others is prohibited. Index Authorization... 3 Introduction...

More information

The World Bank. Aide Memoire for use during GMP inspections

The World Bank. Aide Memoire for use during GMP inspections The World Bank e for use during GMP inspections The World Bank Procurement of Health Sector Goods Contact persons: 0 1. General information about the manufacturer Name of manufacturer Physical address

More information

GxP Auditing, Remediation, and Staff Augmentation

GxP Auditing, Remediation, and Staff Augmentation GxP Auditing, Remediation, and Staff Augmentation TABLE OF CONTENTS 3 Introduction 4 GxP Auditing 4 GMP Auditing 5 GCP Auditing 5 GLP Auditing 6 Pharmacovigilance Auditing 6 Vendor/Supplier Auditing 7

More information

PAI Inspections, Observations and Data Integrity

PAI Inspections, Observations and Data Integrity PAI Inspections, Observations and Data Integrity Krishna Ghosh, Ph.D. Office of Pharmaceutical Quality Office of Process and Facilities Center for Drug Evaluation and Research November, 2017 20 November

More information

EU and FDA GMP Regulations: Overview and Comparison

EU and FDA GMP Regulations: Overview and Comparison THE QUALITY ASSURANCE JOURNAL, VOL. 2, 55 60 (1997) EU and FDA GMP Regulations: Overview and Comparison The increasing emphasis on global supply of drug products, as well as starting materials and investigational

More information

GxP Auditing, Remediation, and Quality System Resourcing

GxP Auditing, Remediation, and Quality System Resourcing GxP Auditing, Remediation, and Quality System Resourcing TABLE OF CONTENTS 3 Introduction 4 GxP Auditing 4 GMP Auditing 5 GCP Auditing 6 GLP Auditing 7 Pharmacovigilance Auditing 7 Vendor/Supplier Auditing

More information

Quality Management System

Quality Management System Quality Management System ZYQ Testing Laboratory 11111 Testing Avenue Testing Town, Alaska 22222 (555) 555-5555 Date Prepared: April 03, 2017 Please note that this Quality Management System (QM) was originated

More information

ASQ Granite State 15 April Audit Planning How Much is Enough?

ASQ Granite State 15 April Audit Planning How Much is Enough? ASQ Granite State 15 April 2014 Audit Planning How Much is Enough? It Depends.. GMP Of Course Announced Unannounced Pre Approval Inspection (PAI) Better be if you submitted the Filing Internal Audit Companies

More information

HAZARD COMMUNICATION PROGRAM YOUR-RIGHT-KNOW CFR

HAZARD COMMUNICATION PROGRAM YOUR-RIGHT-KNOW CFR HAZARD COMMUNICATION PROGRAM YOUR-RIGHT-KNOW CFR 29 1910.1200 0 TABLE OF CONTENTS OUR COMMITMENT...1 PURPOSE...2 INTRODUCTION...2 RESPONSIBILITIES...2 Management, Shipping / Receiving, Safety Representative,

More information

Outsourcing - managing risks and opportunities over which you now have less control

Outsourcing - managing risks and opportunities over which you now have less control Outsourcing - managing risks and opportunities over which you now have less control Kevin O Donnell, PhD PDA Meeting, Dublin 22 nd November 2018 Slide 2 Typical Examples The key GMP Requirements & Guidance

More information